Skip to main content
On Demand

Update on Adult Psychiatric Medications: What Therapists Need to Know


You may earn this many credits: 3.0

Faculty:
Nick Allen, M.D.
Duration:
3.0 Hours
Format:
Audio and Video


Description

This lecture will be organized around the different classes of psychiatric medications (antidepressants, antipsychotics, mood stabilizers, anxiolytics, etc.). We will review evidence based indications for these medicines  and common side effects. We will also discuss mechanisms of action, newer classes of medications (for addiction, dementia), and special considerations (pregnancy and pharmacogenomic testing). Questions are encouraged to foster an open discussion about how psychiatrists and psychologists can collaborate with one another towards optimal recovery for their patients.

This session is at the introductory level and is designed for psychologists and other mental health professionals.

Objectives:

  1. Define pharmacologic classes of medications.
  2. List evidence based indications for each class of medications.
  3. Recognize side effects for each class of medications.

This session qualifies for 3 continuing education credits. You must attend the full program to receive continuing education credit.

The Minnesota Psychological Association is approved by the American Psychological Association to sponsor continuing education for psychologists. The Minnesota Psychological Association maintains responsibility for this program and its content.

This session was cosponsored with the Metropolitan State University Psychology Department.

Handouts

Faculty

Nick Allen, M.D. Related Seminars and Products


Nick Allen, M.D., attended the University of Kansas, where he earned his chemical engineering degree and doctorate of medicine. He completed his psychiatry residency and consultation-liaison fellowship at Mayo Clinic, where he now works as a hospitalist on medical-psychiatry services. He is passionate about learning and teaching in interdisciplinary settings.

The speaker has indicated they do not have any conflicts of interest.